News & Updates
Filter by Specialty:

OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies
Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.
OUtMATCH: Omalizumab gains FDA nod for IgE-mediated food allergies
05 Mar 2024
Hysterectomy for low-risk cervical cancer: Less is more?
In patients with low-risk cervical cancer, simple hysterectomy has demonstrated noninferior pelvic recurrence rate at 3 years and lower rates of surgery-related urologic adverse events (AEs) vs radical hysterectomy in the phase III, randomized, noninferiority CX.5 SHAPE trial.
Hysterectomy for low-risk cervical cancer: Less is more?
05 Mar 2024
Patient blood management is important in improving patient outcomes
The key to familiarizing patient blood management (PBM) among healthcare professionals may lie in identifying PBM as a crucial part of blood health, said Sherri Ozawa, clinical director of Patient Blood Management, Englewood Health, and founding member of the Society for the Advancement of Patient Blood Management (SABM).
Patient blood management is important in improving patient outcomes
05 Mar 2024
Depressed? Do some exercise, says study
People who are suffering from depression may find relief by getting physically active, like walking or jogging, yoga, and strength training, a study suggests. More intense exercises also seem to provide greater benefits in reducing depression, while yoga and strength training are well tolerated versus other treatments.